| 1 | biosplice toggle navigation about | | | | | | | 1 | 0.40% |
| 2 | the resulting proteome diversification | | | | | | | 1 | 0.40% |
| 3 | splicing regulates genome potential | | | | | | | 1 | 0.40% |
| 4 | by differentially joining or | | | | | | | 1 | 0.40% |
| 5 | differentially joining or skipping | | | | | | | 1 | 0.40% |
| 6 | joining or skipping gene | | | | | | | 1 | 0.40% |
| 7 | or skipping gene segments | | | | | | | 1 | 0.40% |
| 8 | skipping gene segments at | | | | | | | 1 | 0.40% |
| 9 | gene segments at alternative | | | | | | | 1 | 0.40% |
| 10 | splice sites the resulting | | | | | | | 1 | 0.40% |
| 11 | sites the resulting proteome | | | | | | | 1 | 0.40% |
| 12 | resulting proteome diversification is | | | | | | | 1 | 0.40% |
| 13 | disease alternative splicing regulates | | | | | | | 1 | 0.40% |
| 14 | proteome diversification is a | | | | | | | 1 | 0.40% |
| 15 | diversification is a fundamental | | | | | | | 1 | 0.40% |
| 16 | physiological aspect of tissue | | | | | | | 1 | 0.40% |
| 17 | aspect of tissue fate | | | | | | | 1 | 0.40% |
| 18 | of tissue fate and | | | | | | | 1 | 0.40% |
| 19 | tissue fate and function | | | | | | | 1 | 0.40% |
| 20 | fate and function conversely | | | | | | | 1 | 0.40% |
| 21 | dysregulated alternative splicing can | | | | | | | 1 | 0.40% |
| 22 | alternative splicing can be | | | | | | | 1 | 0.40% |
| 23 | splicing can be a | | | | | | | 1 | 0.40% |
| 24 | alternative splicing regulates genome | | | | | | | 1 | 0.40% |
| 25 | and disease alternative splicing | | | | | | | 1 | 0.40% |
| 26 | be a root cause | | | | | | | 1 | 0.40% |
| 27 | opposing function through a | | | | | | | 1 | 0.40% |
| 28 | a single gene can | | | | | | | 1 | 0.40% |
| 29 | single gene can translate | | | | | | | 1 | 0.40% |
| 30 | gene can translate into | | | | | | | 1 | 0.40% |
| 31 | can translate into multiple | | | | | | | 1 | 0.40% |
| 32 | translate into multiple protein | | | | | | | 1 | 0.40% |
| 33 | variants with distinct and | | | | | | | 1 | 0.40% |
| 34 | with distinct and sometimes | | | | | | | 1 | 0.40% |
| 35 | distinct and sometimes opposing | | | | | | | 1 | 0.40% |
| 36 | and sometimes opposing function | | | | | | | 1 | 0.40% |
| 37 | sometimes opposing function through | | | | | | | 1 | 0.40% |
| 38 | dynamic and heavily regulated | | | | | | | 1 | 0.40% |
| 39 | splicing and disease alternative | | | | | | | 1 | 0.40% |
| 40 | and heavily regulated mechanism | | | | | | | 1 | 0.40% |